Extracellular Vesicles from Amnion-Derived Mesenchymal Stem Cells Ameliorate Hepatic Inflammation and Fibrosis in Rats
Background. There are no approved drug treatments for liver fibrosis and nonalcoholic steatohepatitis (NASH), an advanced stage of fibrosis which has rapidly become a major cause of cirrhosis. Therefore, development of anti-inflammatory and antifibrotic therapies is desired. Mesenchymal stem cell- (...
Saved in:
Main Authors: | Masatsugu Ohara, Shunsuke Ohnishi, Hidetaka Hosono, Koji Yamamoto, Kohei Yuyama, Hideki Nakamura, Qingjie Fu, Osamu Maehara, Goki Suda, Naoya Sakamoto |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2018/3212643 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Conditioned Medium from Human Amnion-Derived Mesenchymal Stem Cells Regulates Activation of Primary Hepatic Stellate Cells
by: Qingjie Fu, et al.
Published: (2018-01-01) -
Genome-Wide Analysis of DNA Methylation in Human Amnion
by: Jinsil Kim, et al.
Published: (2013-01-01) -
The Influence of the Preservation Method and Gamma Irradiation Sterilization on TGF-β and bFGF Levels in Freeze-Dried Amnion Membrane (FD-AM) and Amnion Sponge
by: Heri Suroto, et al.
Published: (2021-01-01) -
Amnion Epithelial Cells as a Candidate Therapy for Acute and Chronic Lung Injury
by: Ryan J. Hodges, et al.
Published: (2012-01-01) -
Halofuginone- and Chitosan-Coated Amnion Membranes Demonstrate Improved Abdominal Adhesion Prevention
by: Scott Washburn, et al.
Published: (2010-01-01)